Dbv Technologies Stock Today
| DBVT Stock | USD 0.66 0.02 2.94% |
Performance0 of 100
| Odds Of DistressLess than 31
|
DBV Technologies is selling for under 0.66 as of the 19th of April 2024; that is -2.94% down since the beginning of the trading day. The stock's last reported lowest price was 0.66. DBV Technologies has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for DBV Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of October 2014 | Category Healthcare | Classification Health Care |
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 192.34 M outstanding shares of which 548.44 K shares are currently shorted by private and institutional investors with about 8.7 trading days to cover. More on DBV Technologies
Moving together with DBV Stock
| 0.74 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against DBV Stock
| 0.75 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.42 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.41 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
DBV Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DBV Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DBV Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | PierreHenri Benhamou | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering DBV Technologies report their recommendations after researching DBV Technologies' financial statements, talking to executives and customers, or listening in on DBV Technologies' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering DBV Technologies. The DBV consensus assessment is calculated by taking the average forecast from all of the analysts covering DBV Technologies. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to DBV Technologies' liquidity, profitability, solvency, and operating efficiency, DBV Technologies is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of DBV Technologies is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DBV Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to DBV Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand DBV Technologies' financial leverage. It provides some insight into what part of DBV Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DBV Technologies (DBVT) is traded on NASDAQ Exchange in USA. It is located in 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120 and employs 104 people. DBV Technologies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 127.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DBV Technologies's market, we take the total number of its shares issued and multiply it by DBV Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DBV Technologies conducts business under Biotechnology sector and is part of Health Care industry. The entity has 192.34 M outstanding shares of which 548.44 K shares are currently shorted by private and institutional investors with about 8.7 trading days to cover.
DBV Technologies currently holds about 247.97 M in cash with (79.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check DBV Technologies Probability Of Bankruptcy
Ownership AllocationDBV Technologies retains a total of 192.34 Million outstanding shares. Roughly 80.0 percent of DBV Technologies outstanding shares are held by general public with 19.64 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check DBV Ownership Details
DBV Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of DBV Technologies jumping above the current price in 90 days from now is close to 99%. The DBV Technologies probability density function shows the probability of DBV Technologies stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days DBV Technologies has a beta of 0.9319 suggesting DBV Technologies market returns are related to returns on the market. As the market goes up or down, DBV Technologies is expected to follow. Additionally, dBV Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of DBV Technologies to move above the current price in 90 days from now is close to 99 (This DBV Technologies probability density function shows the probability of DBV Stock to fall within a particular range of prices over 90 days) .
DBV Stock Institutional Holders
Institutional Holdings refers to the ownership stake in DBV Technologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of DBV Technologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing DBV Technologies' value.| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2023-12-31 | 93.6 K | |
| Commodore Capital Lp | 2023-12-31 | 92.7 K | |
| Citadel Advisors Llc | 2023-09-30 | 85.5 K | |
| Jane Street Group, Llc | 2023-12-31 | 59.3 K | |
| Cowen And Company, Llc | 2023-12-31 | 51 K | |
| Geode Capital Management, Llc | 2023-12-31 | 38.8 K | |
| Rhumbline Advisers | 2023-12-31 | 29 K | |
| Janney Montgomery Scott Llc | 2023-12-31 | 23.5 K | |
| Commonwealth Equity Services Inc | 2023-12-31 | 17.9 K | |
| Baker Bros Advisors Lp | 2023-12-31 | 14.6 M | |
| Braidwell Lp | 2023-09-30 | 12.1 M |
DBV Technologies Historical Income Statement
DBV Technologies Income Statement is one of the three primary financial statements used for reporting DBV's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of DBV Technologies revenue and expense. DBV Technologies Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, DBV Technologies' Interest Expense is comparatively stable compared to the past year. Gross Profit is likely to gain to about 4.7 M in 2024, whereas Total Revenue is likely to drop 0.00 in 2024. View More FundamentalsDBV Stock Against Markets
Picking the right benchmark for DBV Technologies stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in DBV Technologies stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for DBV Technologies is critical whether you are bullish or bearish towards DBV Technologies at a given time. Please also check how DBV Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in DBV Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
DBV Technologies Corporate Directors
DBV Technologies corporate directors refer to members of a DBV Technologies board of directors. The board of directors generally takes responsibility for the DBV Technologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of DBV Technologies' board members must vote for the resolution. The DBV Technologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Pascale Ehouarn | Industrial Development and Production Director | Profile | |
| Claude Thebault | Medical Director | Profile | |
| Laurent Martin | Director of Regulatory Affairs | Profile | |
| Didier Hoch | Director | Profile |
How to buy DBV Stock?
Before investing in DBV Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in DBV Technologies. To buy DBV Technologies stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of DBV Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase DBV Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located DBV Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased DBV Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as DBV Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.
Already Invested in DBV Technologies?
The danger of trading DBV Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of DBV Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than DBV Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile DBV Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether DBV Technologies is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DBV Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dbv Technologies Stock. Highlighted below are key reports to facilitate an investment decision about Dbv Technologies Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for DBV Stock analysis
When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is DBV Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DBV Technologies. If investors know DBV will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DBV Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Revenue Per Share 0.0825 | Quarterly Revenue Growth 0.144 | Return On Assets (0.22) | Return On Equity (0.43) |
The market value of DBV Technologies is measured differently than its book value, which is the value of DBV that is recorded on the company's balance sheet. Investors also form their own opinion of DBV Technologies' value that differs from its market value or its book value, called intrinsic value, which is DBV Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DBV Technologies' market value can be influenced by many factors that don't directly affect DBV Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DBV Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if DBV Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DBV Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.